Opioid Withdrawal Syndrome (OWS) Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Opioid Withdrawal Syndrome (OWS) Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

“Delveinsight Business Research LLP”
DelveInsight’s “Opioid Withdrawal Syndrome (OWS) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Opioid Withdrawal Syndrome (OWS), historical and forecasted epidemiology as well as the Opioid Withdrawal Syndrome (OWS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

According to the American Addiction Centers, when the use of opiate drugs is stopped, it may produce several withdrawal symptoms and collectively these symptoms are called Opiate Withdrawal Syndrome (OWS). Opiate withdrawal symptoms may range from mild to severe, depending on how dependent the individual is on an opioid drug.

Some of the psychological withdrawal symptoms and cravings for opioid drugs may persist longer than a week in some cases. The withdrawal symptoms are generally not life-threatening, but it causes a tremendous psychological and physical disturbance that often people start reuse of opioids to avoid withdrawal symptoms. This leads to a continuous cycle of stopping and resuming drug use, which makes it difficult to quit later on.

According to the survey by Roger et al. (2014), 56.5% of participants accepted that avoiding withdrawal was their primary current reason for use of opioids.

Get FREE sample copy at: 

The Opioid Withdrawal Syndrome (OWS) market report also covers emerging drugs, current treatment practices, Opioid Withdrawal Syndrome (OWS) market share of the individual therapies, current and forecasted Opioid Withdrawal Syndrome (OWS) Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Opioid Withdrawal Syndrome (OWS) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 


Opioid Withdrawal Syndrome (OWS) Market


Opioid Withdrawal Syndrome (OWS) Market Key Facts

According to the Centers for Disease Control and Prevention, the opioid prescription rate was 75.6% per 100 people in 2014, which decreases to 58.7% per 100 people in 2017. Some counties had an opioid prescription
rate seven times higher than the national average.

In 2017, more than 72,000 Americans died from drug overdoses, including illicit drugs and prescription opioids, a 2-fold increase in a decade. The sharpest increase involved synthetic opioids, primarily fentanyl and fentanyl analogs (similar compounds), with nearly 30,000 overdose deaths, according to the Centers for Disease Control and Prevention.

As per the article by Galofaro et al., the title “AP: Purdue foreign arm caught up in opioid probe in Europe,” Italian consumption of prescription opioids went from 1.1 daily doses per thousand people in 2005 to 4.5 daily doses per thousand people in 2017.

Key Benefits of Opioid Withdrawal Syndrome (OWS) Market Report

  • Opioid Withdrawal Syndrome (OWS) market report provides an in-depth analysis of Opioid Withdrawal Syndrome (OWS) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Opioid Withdrawal Syndrome (OWS) market report will help in developing business strategies by understanding the Opioid Withdrawal Syndrome (OWS) Market trends & developments, key players, and future market competition that will shape and drive the Opioid Withdrawal Syndrome (OWS) market in the upcoming years.

  • The Opioid Withdrawal Syndrome (OWS) market report covers Opioid Withdrawal Syndrome (OWS) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Opioid Withdrawal Syndrome (OWS) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Opioid Withdrawal Syndrome (OWS) Market
The rise in the use of opioids for the treatment of pain and anesthesia as well as misuse will be the key market driver for Opioid Withdrawal Syndrome (OWS).

The Opioid Withdrawal Syndrome (OWS) market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Opioid Withdrawal Syndrome (OWS) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Opioid Withdrawal Syndrome (OWS) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Opioid Withdrawal Syndrome (OWS) Epidemiology
According to National Survey on Drug Use and Health, 5.2 million Americans (2.1% of the US population) used prescription opioids non-medically in the past month.

The Opioid Withdrawal Syndrome (OWS) epidemiology section covers insights about the historical and current Opioid Withdrawal Syndrome (OWS) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Opioid Withdrawal Syndrome (OWS) Drugs Uptake and Key Market Players
The Opioid Withdrawal Syndrome (OWS) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Opioid Withdrawal Syndrome (OWS) market or expected to get launched in the market during the study period. The analysis covers Opioid Withdrawal Syndrome (OWS) market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The available therapeutics treatment options in the OWS landscape aim to provide symptomatic relief arising due to opioid withdrawal. The current clinical pipeline of Opioid Withdrawal Syndrome (OWS) is weak. Some of the key players worldwide are working toward the development of therapies for Opioid Withdrawal Syndrome (OWS).

Opioid Withdrawal Syndrome (OWS) Companies:
Chiesi Farmaceutici
Aphios Corporation
US WorldMeds
And many others.

Opioid Withdrawal Syndrome (OWS) therapies covered in the report include:
Lofexidine hydrochloride (Lucemyra)
And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Opioid Withdrawal Syndrome (OWS) Competitive Intelligence Analysis

4. Opioid Withdrawal Syndrome (OWS) Market Overview at a Glance

5. Opioid Withdrawal Syndrome (OWS) Disease Background and Overview

6. Opioid Withdrawal Syndrome (OWS) Patient Journey

7. Opioid Withdrawal Syndrome (OWS) Epidemiology and Patient Population

8. Opioid Withdrawal Syndrome (OWS) Treatment Algorithm, Current Treatment, and Medical Practices

9. Opioid Withdrawal Syndrome (OWS) Unmet Needs

10. Key Endpoints of Opioid Withdrawal Syndrome (OWS) Treatment

11. Opioid Withdrawal Syndrome (OWS) Marketed Products

12. Opioid Withdrawal Syndrome (OWS) Emerging Therapies

13. Opioid Withdrawal Syndrome (OWS) Seven Major Market Analysis

14. Attribute Analysis

15. Opioid Withdrawal Syndrome (OWS) Market Outlook (7 major markets)

16. Opioid Withdrawal Syndrome (OWS) Access and Reimbursement Overview

17. KOL Views on the Opioid Withdrawal Syndrome (OWS) Market.

18. Opioid Withdrawal Syndrome (OWS) Market Drivers

19. Opioid Withdrawal Syndrome (OWS) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Latest BioPharma Blog – Smoking Cessation Emerging Therapies

 About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/